EMBC
Embecta Corp.NASDAQHealthcare$8.85+0.68%ClosedMarket Cap: $524.1M
As of 2026-04-06
Valuation
P/E (TTM)
3.76
PEG
0.03
P/B
-0.84
P/S
0.49
EV/EBITDA
4.95
DCF Value
$36.00
FCF Yield
39.3%
Div Yield
6.8%
Margins & Returns
Gross Margin
63.7%
Operating Margin
32.1%
Net Margin
12.9%
ROE
-20.9%
ROA
13.4%
ROIC
29.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $261.2M | 67.2% | $97.1M | $44.1M | $0.74 | $0.15 |
| Q4 2025 | $264.0M | 59.1% | $64.4M | $26.4M | $0.45 | $0.15 |
| FY 2025 | $1.08B | 62.9% | $329.3M | $95.4M | $1.62 | $0.60 |
| Q3 2025 | $295.5M | 66.0% | $106.1M | $45.5M | $0.78 | $0.15 |
| Q2 2025 | $259.0M | 62.4% | $78.5M | $23.5M | $0.40 | $0.15 |
| Q1 2025 | $261.9M | 63.7% | $76.9M | $-700.0K | $-0.01 | $0.15 |
| Q4 2024 | $286.1M | 59.9% | $33.6M | $14.6M | $0.25 | $0.15 |
| FY 2024 | $1.12B | 64.9% | $174.2M | $78.3M | $1.34 | $0.60 |
| Q3 2024 | $272.5M | 69.0% | $55.9M | $14.7M | $0.25 | $0.15 |
| Q2 2024 | $287.2M | 64.1% | $39.2M | $28.9M | $0.50 | $0.15 |
| Q1 2024 | $277.3M | 67.0% | $47.4M | $20.1M | $0.35 | $0.15 |
| Q4 2023 | $281.9M | 64.5% | $31.5M | $6.0M | $0.10 | $0.15 |